Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.61-$2.53 |
Market Cap | $963.9M |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $69.6M |
Revenue Growth (YoY) | 1,572.1% |
Gross Profit (12 Mos) | $63M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 8 days ago
Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)
Yahoo Finance • 20 days ago
Lexicon (LXRX) Reports $21.1M Q1 Revenue Driven by Novo Nordisk Milestones
Yahoo Finance • 27 days ago
Novo Nordisk Extends Pipeline With Semaglutide Alcohol Study And LX9851 Trial
Yahoo Finance • 29 days ago
Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |